Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyopathic changes

References

• Schultheiss HP, Bolte HD. Immunological analysis of autoantibodies against the adenosine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17: 603–617
   PubMed Web of Science ®Google Scholar
• Wolff PG, Kuhl U, Schultheiss HP. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J 1989; 117: 1303–1309
   PubMed Web of Science ®Google Scholar
• Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, et al. Mapping of a functional autoimmune epitope on the β 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658–1663
   PubMed Web of Science ®Google Scholar
• Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patient with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839–846
   PubMedGoogle Scholar
• Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15: 1527–1534
   PubMed Web of Science ®Google Scholar
• Fu MLX, Magnusson Y, Berch CH, Liljeqvist JA, Waagstein F, Hjalmarson A, et al. Localization of functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Investig 1993; 91: 1964–1968
   PubMed Web of Science ®Google Scholar
• Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of anti-heart antibodies in patient with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993; 22: 1378–1384
   PubMed Web of Science ®Google Scholar
• Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994; 23: 146–153
   PubMedGoogle Scholar
• Fu LXM, Hoebeke J, Matsui S, Matoba M, Magnusson Y, Hedner T, et al. Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 1994; 72: 15–20
   PubMedGoogle Scholar
• Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the β 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89: 2760–2767
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu LXM, Shimizu M, Fukuoka T, Teraoka K, Takekoshi N, et al. Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 1995; 21: 85–88
   PubMed Web of Science ®Google Scholar
• Magnusson Y, Wallukat G, Guillet JG, Hjalmarson A, Hoebeke J. Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the β 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmun 1991; 4: 893–905
   PubMedGoogle Scholar
• Wallukat G, Wollenberg A, Morwinski R, Pitschner HF. Anti-β 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995; 27: 397–406
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu LXM, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29: 641–655
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu LXM, Hayase M, Katsuda S, Yamaguchi N, Teraoka K, et al. Active immunization o combined β1-adrenoceptor and M2-muscarinic receptor peptide induces cardiac hypertrophy in rabbits. J Card Fail 1999; 5: 246–254
   PubMedGoogle Scholar
• Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527–530
   PubMed Web of Science ®Google Scholar
• Schwimmbeck PL, Badorff C, Schultheiss HP, Strauer BE. Transfer of human myocarditis into severe combined immunodeficiency mice. Cir Res 1994; 75: 156–164
   PubMed Web of Science ®Google Scholar
• Omerovic E, Bollano E, Andersson B, Kujacic V, Schulze W, Hjalmarson A, et al. Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity 2000; 32: 271–280
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu LXM, Hayase M, Katsuda S, Yamaguchi N, Teraoka K, et al. Transfer of rabbits autoimmune cardiomyopathy into severe combined immunodeficiency mice. J Cardiovasc Pharmacol 2003; 42(Suppl 1)S99–S103
   Google Scholar
• Armstrong AT, Binkley PF, Baker PB, Myerowitz PD, Leier CV. Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol 1998; 32: 704–710
   PubMedGoogle Scholar
• Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564–1575
   PubMed Web of Science ®Google Scholar
• Maisch B, Hufnagel G, Schonian U, Herzum M, Ritter M, Richter A. Autoimmunity in dilated cardiomyopathy. Heart Failure Rev 1996; 1: 173–182
   Google Scholar
• Rose NR, Bona C. Defining criteria for autoimmune diseases. Immunol Today 1993; 14: 426–430
   PubMedGoogle Scholar
• Hayase M, Matsui S, Katsuda S, Teraoka K, Kurihara T, Yamaguchi N, et al. Immune mechanism of myocardial injury due to anti-β1-adrenoceptor autoantibody: Immunohistological study of myocardial disorder. J Cardiovasc Pharmacol 1999; 34(Suppl 4)S29–S32
   Google Scholar
• Fu LXM, Magnusson Y, Bergh GH, Liljequist J-A, Waagstein F, Hjalmarson A, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964–1968
   PubMed Web of Science ®Google Scholar
• Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989; 65: 657–670
   PubMed Web of Science ®Google Scholar
• Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, et al. Effects of chronic β-adrenergic receptor stimulation in mice. J Mol Cell Cardiol 1997; 29: 2735–2746
   PubMedGoogle Scholar
• Vladutiu AO. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 1993; 93: 1–8
   PubMed Web of Science ®Google Scholar
• Duchosal MA, McConahey PJ, Robinson CA, Dixon FJ. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 1990; 172: 985–988
   PubMed Web of Science ®Google Scholar
• Macht L, Fukuma N, Leader K, Sarsero D, Pegg CA, Phillips DI, et al. Severe combined immunodeficient (SCID) mice: A model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 1991; 84: 34–42
   PubMed Web of Science ®Google Scholar
• Krams SM, Dorshkind K, Gershwin ME. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 1989; 170: 1919–1930
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Yoshimura M, Harada E, Nakayama M, Sakamoto T, Shimasaki Y, et al. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 86: 1036–1040
   PubMedGoogle Scholar
• Steinhelper ME. Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Cir Res 1993; 72: 984–992
   PubMed Web of Science ®Google Scholar